期刊文献+

青少年慢性肾脏病患者血管内膜中膜厚度变化与胎球蛋白-A的关系

下载PDF
导出
摘要 慢性肾脏病(CKD)患者和正常人群相比过早的发生动脉粥样硬化和血管硬化。在这类患者中,血管壁的改变不仅在成年人中发生,也可在青少年中发生。在儿童慢性肾脏病患者中,35%~50%的死亡人数是由心血管疾病造成的,依靠透析治疗而生存下来的青年儿童数目不断增加,资料表明随着时间的延长,会激发影响其长期预后的动脉变化。高分辨率颈动脉超声是一种能够评估成人和儿童血管改变的有效方法,无论在一般人群中还是在终末期肾脏病患者中,
出处 《中国血液净化》 2009年第2期98-100,共3页 Chinese Journal of Blood Purification
  • 相关文献

参考文献11

  • 1Nayir A, Bilge I, Kilicaslan I, et al. Arterial changes in paediatric haemodialysis patients undergoing renal transplantation[J]. Nephrol Dial Transplant, 2001,16:2041- 2047.
  • 2McDonald SP, Craig JC .Long-term survival of children with end-stage renal disease[J]. N Engl J Med ,2004, 350: 2654-2662.
  • 3艾乙,夏青.正常儿童颈动脉双功能彩色多普勒检测值研究[J].中国儿童保健杂志,2004,12(1):20-22. 被引量:10
  • 4GoodmanWG, Goldia J, Kuizon BD, et al. Coronary-artery calcification in young adults with endstage renal disease who are undergoing dialysis[J]. N Engl J Med, 2000,342: 1478-1448.
  • 5Tamashiro M, Iseki K, Sunagawa O, et al. Significant association between progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis[J]. Am J Kidney Dis, 2001,38:64-69.
  • 6姚英,刘惠兰,王银娜,刘群.血液透析患者血磷水平与颈动脉内-中膜厚度的关系[J].中国血液净化,2007,6(8):411-414. 被引量:12
  • 7Reynolds JL, Joannides AJ, Skepper JN, et al. Human vascular smooth muscle cells undergo vesiclemediated cal- cification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD[J]. J Am Soc Nephrol, 2004, 15:2857-2867
  • 8Ketteler M,Bongartz P, Westenfeld R, et al. Association of low fetuin-A(AHSG)concentrations in serum with cardiovascular mortality in patients on dialysis:a cross-sectional study[J].Lancet, 2003,361(9360):827-833.
  • 9梁馨苓,史伟,章斌,刘双信,林秋雄,黄美萍,王文健,叶智明,何朝生.终末期肾病患者心血管事件与血清胎球蛋白A及冠脉钙化的关系[J].中华肾脏病杂志,2006,22(6):336-340. 被引量:25
  • 10王开 ,钱家麒 ,Peter Stenvinkel ,Bengt Lindholm .终末期肾衰竭患者血清胎球蛋白A水平改变与临床预后的关系[J].中华肾脏病杂志,2005,21(2):72-75. 被引量:21

二级参考文献52

  • 1王开 ,钱家麒 ,Peter Stenvinkel ,Bengt Lindholm .终末期肾衰竭患者血清胎球蛋白A水平改变与临床预后的关系[J].中华肾脏病杂志,2005,21(2):72-75. 被引量:21
  • 2Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med, 2000,342:1478-1483.?A?A?A
  • 3Schinke T, Amendt C, Trindl A, et al. The serum protein alpha2-HS glycoprotein/fetuin inhibites apatite formation in vitro and in mineralizing calvaria cells: a possible role in mineralization and calcium homeostasis. J Biol Chem, 1996,271: 20789-20796.
  • 4Jahnen-Dechent W, Schinke T, Trindl A, et al. Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem,1997,272: 31496-31503.
  • 5Schinke T, Karsenty G. Vascular calcffication-a passive process in need of inhibitors. Nephrol Dial Transplant, 2000, 15:1272-1274.
  • 6Binkert C, Dementriou M, Sukhu B, et al. Regulation of osteogenesis by fetuin. J Biol Chem, 1999, 274:28514-28520.
  • 7Ruminy P, Gangneux C, Claeyssens S, et al. Gene transcription in hepatocytes during the acute phase of a systemic inflammation: from transcription factors to target genes. Inflamm Res, 2001, 50:383-390.
  • 8Ombrellino M, Wang H, Yang H, et al. Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan. Shock, 2001, 15:181-185.
  • 9Wang H, Zhang M, Bianchi M, et al. Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules. Proc Natl Acad Sci USA, 1998, 95:14429-14434.
  • 10Mathews ST, Chellam N, Srinivas PR, et al. Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation,interacts with the insulin receptor. Mol Cell Endocrinol, 2000,164:87-98.

共引文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部